Montréal, Québec, August 11th, 2014 – FAAH Pharma Inc., today announced an investment by TVM Life Science Ventures VII into the company. FAAH Pharma Inc. will continue the clinical development of a compound with the potential to treat neuropathic pain. The asset has been tested in the clinic in healthy volunteers and will be studied […]
News releases of TVM Capital Life Science portfolio companies.
Dr. Helmut Schühsler, Chairman and Dr. Hubert Birner, Managing Partner together with around 120 guests from the international VC industry celebrated the firm’s 30th anniversary in Munich on July 24th. TVM Capital was one of the pioneers of the industry in Germany and Europe with a strong transatlantic investment focus on innovation-driven companies. Today the […]
-Data in Journal of Vascular Surgery Demonstrate Potential to Improve Function and Durability of Vascular Access Required for Hemodialysis- WALTHAM, Mass. – May 14, 2014 – Proteon Therapeutics Inc., a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with kidney and vascular diseases, today announced the online […]
Montréal, Québec, May 12th, 2014 –TVM Life Science Ventures VII today announced the fund’s fourth investment, a co-investment with the Fonds de solidarité FTQ (the “Fonds”) – establishing PRCL Research Inc., a company based in Montréal, Québec. PRCL Research Inc. plans to develop, to proof-of-concept, a compound originally discovered by Synta Pharmaceuticals Inc. with the […]
Significant financing to accelerate industrialization and commercialization of invendo’s single-use colonoscope – Kissing, Germany – Garden City, NY — March 20, 2014 — invendo medical, manufacturer and distributor of a single-use and computer-assisted colonoscopy system, today announced the closing of a € 20.3 million ($ 28 million) financing round led by new investor Xeraya Capital […]